2型糖尿病成人无论C肽水平如何均从自动胰岛素输注中获益
该研究基于随机试验数据,将接受胰岛素治疗的2型糖尿病成人按CMS标准分为高C肽组(n=195)和低C肽组(n=59)。结果显示,自动胰岛素输注(AID)组平均HbA1c较基线下降0.8%,在高C肽组(P<0.001)和低C肽组(P=0.02)均显著优于对照组,且≥65岁参与者结果相似。结论认为,要求低C肽水平作为AID治疗前提并不合理。
要点
- AID在高C肽和低C肽的2型糖尿病成人中均显著降低HbA1c。
- ≥65岁参与者中AID的获益与总体人群相似。
- 以低C肽作为AID报销门槛缺乏依据。
核心结论
- AID的获益在高C肽和低C肽水平的2型糖尿病成人中均存在。
- 要求低C肽水平作为AID治疗的前提条件并不合理。
研究设计与样本
- 随机试验评估t:slim X2胰岛素泵联合Control-IQ+技术在胰岛素治疗的2型糖尿病成人中的疗效与安全性。
- 按CMS标准将参与者分为高C肽组(n=195)和低C肽组(n=59)。
主要发现
- AID组平均HbA1c较基线下降0.8%,显著大于对照组在高C肽组(P<0.001)和低C肽组(P=0.02)的下降。
- ≥65岁参与者的结果与总体人群相似。
关键数值与推荐
- 高C肽组:AID组HbA1c下降0.8%,优于对照组(P<0.001)。
- 低C肽组:AID组HbA1c下降0.8%,优于对照组(P=0.02)。
临床怎么用
- 对于胰岛素治疗的2型糖尿病成人,不应仅因C肽水平高而排除AID治疗。
- ≥65岁的2型糖尿病成人也可从AID中获益。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The Centers for Medicare & Medicaid Services (CMS) requires a low C-peptide level for insulin pump coverage unless the individual is β-cell autoantibody positive, which precludes coverage of automated insulin delivery (AID) systems for many people with type 2 diabetes. RESEARCH DESIGN AND METHODS: In the Randomized Trial Evaluating the Efficacy and Safety of Control-IQ+ Technology in Adults With Type 2 Diabetes Using Basal-Bolus Insulin Therapy study evaluating the t:slim X2 insulin pump with Control-IQ+ technology, adults with insulin-treated type 2 diabetes were categorized into high C-peptide (n = 195) and low C-peptide (n = 59) groups based on CMS criteria. RESULTS: In the AID group, mean HbA1c decreased from baseline by 0.8%, which was significantly greater than in the control group with both high (P < 0.001) and low (P = 0.02) C-peptide levels. Results were similar in participants ≥65 years old. CONCLUSIONS: The benefit of AID is present with high and low C-peptide levels. Thus, requiring a low C-peptide level as a prerequisite for AID therapy is not warranted.
引用
- Hirsch IB, Kudva YC, Ahn DT, et al. Adults With Type 2 Diabetes Benefit From Automated Insulin Delivery Irrespective of C-Peptide Level. Diabetes Care. 2025. PMID: 40953318. doi:10.2337/dc25-1125
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。